Ryo Kamata

7PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 30, 2026
Neoadjuvant olaparib and pembrolizumab combination therapy in the treatment of patients with HRD-positive advanced ovarian cancer: A pilot study.

|Nov 19, 2023
CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockade.

Tomoko Yamamori Morita, Jie Yu, Yukie Kashima

|Nov 04, 2023
Wnt activation disturbs cell competition and causes diffuse invasion of transformed cells through NF-κB-MMP21 pathway.

Kazuki Nakai, Hancheng Lin, Shotaro Yamano

|Jul 31, 2020
NLRP3 Inflammasome Activation in Lung Vascular Endothelial Cells Contributes to Intestinal Ischemia/Reperfusion-Induced Acute Lung Injury.

Homare Ito, Hiroaki Kimura, Tadayoshi Karasawa

|Jul 19, 2019
Crucial Role of NLRP3 Inflammasome in the Development of Peritoneal Dialysis-related Peritoneal Fibrosis.

Erika Hishida, Homare Ito, Takanori Komada

|May 22, 2019
Inflammasome-Independent and Atypical Processing of IL-1β Contributes to Acid Aspiration-Induced Acute Lung Injury.

Yoshiko Mizushina, Tadayoshi Karasawa, Kenichi Aizawa

Pageof 2

Frequent Collaborators

3 joint publications

Hiroaki Kimura

3 joint publications

Masafumi Takahashi

3 joint publications

Akihiro Ohashi

2 joint publications

Takanori Komada